| EPIC |
BVXP |
| Sector |
Pharma and Biotech |
| ISIN |
GB00B4QVDF07 |
| Market Sector |
AIM |
| Market Segment |
ASQ1 |
| Main Indices |
FTSE AIM All-Share |
| Country of register |
Great Britain |
| Currency |
British Pound |
| Market Cap |
£94.05m |
| NMS |
200 |
| Shares in issue |
5.22m |
| Date Listed |
29-Apr-2014 |
| |
Interim |
2nd Interim |
| Ex-Div |
09-Apr-26 |
06-Nov-25 |
| Paid |
24-Apr-26 |
21-Nov-25 |
| Amount |
70.00p |
80.00p |
| 15:15 |
34 @ 1,775.00p |
| 15:11 |
34 @ 1,775.00p |
| 14:51 |
406 @ 1,848.00p |
| 14:44 |
615 @ 1,828.00p |
| 14:09 |
97 @ 1,771.00p |
| CEO |
Peter John Harrison |
| Chair |
Ian James Nicholson |
| CFO |
Bruce Hiscock |
Top of Page
You are here:
research